Genetic And Metabolic Determinants Of Spontaneous Physical Activity
Funder
National Health and Medical Research Council
Funding Amount
$67,828.00
Summary
It could be argued that obesity is the most significant public health problem facing Australians today. Almost one in five adult Australians are obese, making them highly susceptible to diabetes, coronary heart disease, high blood pressure, high blood lipid levels, and some cancers, as well as reduced psychosocial health. There is therefore an urgent need to reduce the prevalence of obesity in our society. Unfortunately, attempts to sustain significant weight loss by dieting and exercise are nea ....It could be argued that obesity is the most significant public health problem facing Australians today. Almost one in five adult Australians are obese, making them highly susceptible to diabetes, coronary heart disease, high blood pressure, high blood lipid levels, and some cancers, as well as reduced psychosocial health. There is therefore an urgent need to reduce the prevalence of obesity in our society. Unfortunately, attempts to sustain significant weight loss by dieting and exercise are nearly always unsuccessful and none of the anti-obesity drugs currently on the market are safe to use long-term. Effective treatments for obesity are only likely to be developed once we understand more about what controls body weight regulation. An inactive lifestyle is clearly a risk factor for obesity. Spontaneous physical activity (or activity associated with daily life, as opposed to formal exercise) can play a major role in determining body weight. Recent work suggests that spontaneous physical activity is influenced not only by our environment but by our biological makeup as well (i.e. genetic and metabolic factors). The aim of this study is to investigate what some of these factors are, and whether they are responsible for altering body weight regulation in animal models of obesity. Specifically we will be looking at whether spontaneous physical activity is influenced by circulating hormones (such as leptin, oestrogen, and pancreatic polypeptide) and a messenger molecule (nitric oxide), and we will also identify genes which influence physical activity in a mouse model of obesity. By examining the genetic and metabolic basis of inactivity in obese rodent models, this project will further our understanding of how energy balance is disturbed in obesity in the hope of developing better therapies to treat obesity in the future.Read moreRead less
Determinants Of Insulin-like Growth Factor (IGF) Binding And Biological Actions Of IGF Binding Protein-6
Funder
National Health and Medical Research Council
Funding Amount
$399,750.00
Summary
Proteins are complex structures usually consisting of a number of distinct regions. Each of these regions may serve different roles. Insulin-like growth factors (IGFs) are important proteins involved in regulating the growth and other properties of cells. The actions of IGFs are in turn regulated by a family of binding proteins (IGFBPs). The aim of this project is to determine the range of actions of one of these IGFBPs and which parts of this IGFBP are involved in these actions. This may lead t ....Proteins are complex structures usually consisting of a number of distinct regions. Each of these regions may serve different roles. Insulin-like growth factors (IGFs) are important proteins involved in regulating the growth and other properties of cells. The actions of IGFs are in turn regulated by a family of binding proteins (IGFBPs). The aim of this project is to determine the range of actions of one of these IGFBPs and which parts of this IGFBP are involved in these actions. This may lead to new treatments for diseases in which cell growth is disturbed e.g. cancer and diabetes.Read moreRead less
Interactions Between IGFBP-3 And TGFbeta In The Inhibition Of Breast Cancer Cell Growth
Funder
National Health and Medical Research Council
Funding Amount
$662,970.00
Summary
A protein first identified by our research group, called insulin-like growth factor binding protein-3 or IGFBP-3, has been shown to be a potent inhibitor of the growth of cancer cells. High levels of IGFBP-3 in the bloodstream are associated with a decreased risk of several cancer types, including breast cancer. However, the way in which this protein prevents cancer cells from growing is poorly understood. This project will investigate an entirely novel idea, developed in our laboratory, that th ....A protein first identified by our research group, called insulin-like growth factor binding protein-3 or IGFBP-3, has been shown to be a potent inhibitor of the growth of cancer cells. High levels of IGFBP-3 in the bloodstream are associated with a decreased risk of several cancer types, including breast cancer. However, the way in which this protein prevents cancer cells from growing is poorly understood. This project will investigate an entirely novel idea, developed in our laboratory, that the actions of IGFBP-3 are intimately connected with the actions of another known cell growth inhibitor called transforming growth factor beta (TGFbeta). We have found that these two proteins initiate the same sequence of events leading to growth inhibition in breast cancer cells, and that a receptor protein required for TGFbeta activity is also needed for IGFBP-3 to be inhibitory. Our work has the potential to explain for the first time exactly how IGFBP-3 stops cancer cells from growing. This is important because it is an abundant protein in the body, and understanding how it acts may lead to the development of new approaches to cancer therapy that exploit our findings.Read moreRead less